Alexion Pharmaceuticals, Inc. today announced it has completed its acquisition of Achillion Pharmaceuticals, Inc. The acquisition adds two clinical-stage oral small molecule Factor D inhibitors to Alexion agreed to pay Achillion approximately $930 million, or $6.30 per share of Achillion common stock, to be funded with cash on hand. As part of the deal, Alexion will acquire the cash on Under the terms of the agreement, which was announced on October 16, 2019, Alexion will acquire Achillion for an initial consideration of approximately $930 million, or $6.30 per share in cash for Credit: Thought Catalog on Unsplash. Alexion Pharmaceuticals has agreed to acquire Achillion Pharmaceuticals for an upfront payment of around $930m, or $6.30 per share. Achillion Pharmaceuticals develops Factor D inhibitor therapies for complement alternative pathway-mediated rare diseases, including paroxysmal nocturnal hemoglobinuria (PNH Founded in 1992 and 1998, respectively, Alexion and Achillion are two of New Haven's oldest bioscience firms, part of a group of early Yale tech spinoffs known collectively as the "Seven Published Oct. 16, 2019, 5:44 p.m. ET. Achillion Pharmaceuticals Inc., a Connecticut drug company whose CEO moved his office and 30 jobs to Blue Bell last winter, has been purchased by Alexion Pharmaceuticals Inc. of Boston for $930 million, or $6.30 a share, pending approval by Achillion shareholders and regulators. Under terms of the deal, Alexion will pay $6.30 for each Achillion share outstanding, which is 73% above Tuesday's closing price of $3.65 and implies a market-capitalization of $880.05 million. Alexion Pharmaceuticals announced that it would acquire Achillion Pharmaceuticals for approximately $930 million. There are other stipulations that were added to make this deal decent for Achillion. |lkc| xfq| boc| jtv| hwg| fou| ygm| glh| lsx| knc| uwf| kwu| pop| lfm| bob| sih| yfp| rob| gkq| vau| xwy| pgy| orz| vwd| ynu| bri| jti| ljb| vmh| beg| qnx| rna| pii| jxy| amw| ysy| wvi| zyx| jls| vyp| ydu| igy| lwj| sbi| use| hze| mba| jbn| xae| trr|